Showing 61-80 of 176 for: EBMG evidence summaries > Oncology 
- Exercise interventions for shoulder dysfunction in patients treated for head and neck cancer
EBMG evidence summaries, 31-May-2012
Progressive resistance training may be more effective than standard physiotherapy treatment for shoulder dysfunction in patients treated for head and neck cancer, improving pain, disability and range of motion of the shoulder joint, but it does not improv
- Follow-up of treated early breast cancer
EBMG evidence summaries, 20-Mar-2003
Follow-up based on regular physical examinations and yearly mammography is as effective than more intensive follow-up in patients with early breast cancer (clinical stage I, II or III) for overall and disease-free survival.
- Follow-up strategies for patients treated for non-metastatic colorectal cancer
EBMG evidence summaries, 29-Apr-2007
There is an overall survival benefit for intensifying the follow-up of patients after curative surgery for colorectal cancer, but the best combination and frequency of visits to doctor, blood tests, endoscopic procedures, and radiological investigations r
- Granulocyte transfusions for treating infections in neutropenic patients
EBMG evidence summaries, 18-Aug-2010
Evidence is inconclusive to support or refute generalised use of granulocyte transfusions to treat infections in patients with neutropenia caused by chemotherapy.
- Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver
EBMG evidence summaries, 3-Dec-2009
Chemotherapy delivered via the hepatic artery following surgical resection of liver metastases arising from colorectal cancer may not improve survival.
- High-dose chemotherapy followed by autologous stem cell transplantation (HDT) as first-line therapy in aggressive non-Hodgkin's lymphoma (NHL)
EBMG evidence summaries, 15-Apr-2008
High-dose chemotherapy followed by autologous stem cell transplantation (HDT) is not more effective in improving overall survival in low-risk patients than control therapies (CT) as initial therapy for aggressive NHL. Poor risk patients seem to benefit fr
- High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults
EBMG evidence summaries, 24-Feb-2012
In previously untreated patients with follifular lymphoma there is a strong progression free survival benefit for high-dose therapy + autologous stem cell transplantation compared with chemotherapy or immuno-chemotherapy. In patients with relapsed disea
- HIV sexual risk reduction interventions in women
EBMG evidence summaries, 20-Mar-2003
Theory-driven, peer-led, multiple-session behavioural interventions that address gender relationships are effective in increasing condom use.
- Hydroxyurea in the treatment of high-risk essential thrombocythaemia
EBMG evidence summaries, 25-Jul-2005
Hydroxyurea plus low-dose aspirin appears to be more effective than anagrelide plus low-dose aspirin for patients with essential thrombocythaemia and high risk for vascular events.
- Hyperbaric oxygen therapy for late radiation tissue injury
EBMG evidence summaries, 8-Oct-2012
Hyperbaric oxygen therapy (HBOT) may improve the outcomes in the treatment of radiation injuries of the head and neck region, anal region and rectum.
- Hyperbaric oxygenation for tumour sensitisation to radiotherapy
EBMG evidence summaries, 10-Sep-2012
Breathing hyperbaric oxygen (HBO) during radiotherapy for cancer treatment may reduce the risk of death and local recurrence within five years for head and neck cancer, and of recurrence within two years for cancer of the cervix.
- Immunosuppression for dermatomyositis and polymyositis
EBMG evidence summaries, 22-Nov-2012
The evidence is lacking about the use of immunosuppressant and immunomodulatory agents in dermatomyositis and polymyositis.
- Immunosuppressive treatment for multifocal motor neuropathy
EBMG evidence summaries, 27-Sep-2011
In multifocal motor neuropathy mycophenolate mofetil might possibly not be beneficial. There is no evidence from randomised controlled trials of other immunosuppressive treatments.
- Interferon alfa versus chemotherapy for chronic myeloid leukemia
EBMG evidence summaries, 20-Mar-2003
For patients with Philadelphia chromosome positive chronic myeloid leukaemia the inclusion of interferon alfa in the therapeutic regimen produces substantially better 5-year survival than standard chemotherapy alone.
- Interleukin 2 receptor antagonists for kidney transplant recipients
EBMG evidence summaries, 23-Apr-2010
Interleukin 2 receptor antagonists for prophylaxis against acute rejection in kidney transplant recipients are as effective as other antibody therapies and with significantly fewer side effects.
- Interventions for enhancing medication adherence
EBMG evidence summaries, 28-May-2008
Improving short-term adherence to medication appears to be relatively successful with a variety of simple interventions. Improving adherence for chronic health problems appears to be only moderately effective and needs mostly complex interventions.
- Interventions for oral mucositis in patients receiving treatment for cancer
EBMG evidence summaries, 19-Aug-2010
Low level laser treatment might possibly be beneficial in reducing the severity of mucositis, although the evidence is insufficient on interventions for oral mucocitis in patients receiving treatment for cancer.
- Interventions for reducing mother-to-child transmission of HIV infection
EBMG evidence summaries, 15-Aug-2007
Zidovudine, nevirapine and delivery by elective caesarean section are very effective in decreasing the risk of mother-to-child transmission of HIV infection.
- Interventions to enhance return-to-work for cancer patients
EBMG evidence summaries, 29-Sep-2011
Multidisciplinary interventions might possibly enhance return-to-work compared to usual care for patients with cancer, but the evidence is insufficient for conclusions.
- Interventions to reduce HIV risk with heterosexual men
EBMG evidence summaries, 6-Aug-2003
Interventions targeting heterosexual men on HIV sexual risk appear to lead to decreases in HIV risk behaviour.
